InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Rabinowitz Michael, Responsable Commercial. Officer active across 1 company, notably Oramed Pharmaceuticals INC.. In total, 5 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €17k. History available since 4 August 2021. The latest transaction was filed on 3 January 2023 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Rabinowitz Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
1,425 shares@ US$13.01327.4% of flowCommon StockSEC:0001209191-23-000517:0
30,000 sharesCommon StockSEC:0001209191-22-043764:0
19,000 sharesCommon StockSEC:0001213900-22-000814:0
9,532 shares@ US$12.9886.3% of flowCommon StockSEC:0001213900-21-068230:0
100,000 shares0Common StockSEC:0001213900-21-040761:0
5 of 5 declarations
About Rabinowitz Michael
Michael Rabinowitz is the Chief Commercial Officer at ORAMED PHARMACEUTICALS INC. He is responsible for managing the company's sales and business development. His expertise in commercial strategy is essential to support growth and optimize financial results. Michael also plays a key role in establishing strategic partnerships and expanding into new markets.
